Large-scale testing (Phase 3)Study completedNCT03362814
What this trial is testing
Efficacy and Safety of Ravidasvir in Combination With Danoprevir/r and Ribavirin(RBV) in Treatment-naive, Non-cirrhotic, Chronic Hepatitis C Virus Genotype1 Infected Subjects.
Who this might be right for
HCV
Ascletis Pharmaceuticals Co., Ltd. 425